ArticleCancer medicine2021

Cost-effectiveness analysis of first-line treatments for advanced epidermal growth factor receptor-mutant non-small cell lung cancer patients.

Wen-Qian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.